We therefore conclude that this is the first documented case of PLNEMP that evolved into “myeloma-like” bone destruction while retaining minimal marrow involvement, a trajectory underscored by the novel IGH::NFKB1 fusion identified by comprehensive molecular profiling. Here, NFKB1 is linked to plasma cell myeloma.